Join Mary Rofael MD, President of ProEd, and a panel of industry experts to discuss how to interpret and communicate data from clinical trials disrupted due to the COVID-19 pandemic.
https://t.co/hCoEudXLhK
#clinicaltrials#FDA#EMA#ProEd#coronavirus#covid19#medcomms
The @hcgint team is making a splash at the 15th Annual Meeting of @ISMPP! We're ready to share ideas with colleagues and clients to move the needle in medical communications!
https://t.co/CXueRYEmLG #HCG
#HCG is making a splash at @eyeforpharma Philadelphia. We are chairing the medical affairs track, giving two presentations on innovative topics, and hosting a fun and engaging booth.
https://t.co/CXueRYEmLG #EFPphilly
Does the new #ICMJE requirement for #datasharing statements mean that #clinicaltrial data must be shared? Visit our blog to learn more! https://t.co/X1jTgJiR8C
Developing a new drug is a costly and high-risk enterprise. But developing a TPP and proactively updating it can improve the odds of success. Read more on our blog: https://t.co/CodZX6RfxR
In a world where technology continues to offer a platform for efficiency and accuracy, the development of the CPT is a welcome addition to the medical field. It is only a matter of time before its use becomes commonplace in drug development. https://t.co/o3wUczHp31
A dynamic TPP to guide drug development from discovery to commercialization is key to mapping a successful path to label optimization https://t.co/w9yXAGqxxo